O
ORIC PHARMACEUTICALS INC
NASDAQ: ORIC (Oric Pharmaceuticals, Inc.)
Last update: 18 hours ago9.24
0.25 (2.78%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Oric Pharmaceuticals, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | 0.0 |
| Price Volatility | 0.4 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -3.5 |
| Relative Valuation | NA |
| Financial Health | 0.0 |
| Macro Environment | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -0.91 |
Select this tab to load the latest available analysis.
|
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 7.93% |
| % Held by Institutions | 102.70% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Aihc Capital Management Ltd | 30 Jun 2026 | 3,828,460 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| PISCITELLI DOMINIC | - | 13.78 | -14,000 | -192,920 |
| Aggregate Net Quantity | -14,000 | |||
| Aggregate Net Value ($) | -192,920 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 13.78 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| PISCITELLI DOMINIC | Officer | 20 Oct 2026 | Automatic sell (-) | 14,000 | 13.78 | 192,920 |
| PISCITELLI DOMINIC | Officer | 20 Oct 2026 | Option execute | 14,000 | - | - |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |